. 2023 Nov 21;17:1634. doi: 10.3332/ecancer.2023.1634
© the authors; licensee ecancermedicalscience.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 3. Progression-free and SR at 6, 12, 18, 24 and 30 months.
